Hillary Mulder

Aug 1, 2024 | jrheum.org | Isaac Smith |Mary Solomon |Hillary Mulder |Catherine Sims

Evaluating Factors Associated With Telehealth Appropriateness in Outpatient Rheumatoid Arthritis Encounters Using the Encounter Appropriateness Score for You (EASY) Isaac D. Smith, Mary J. Solomon, Hillary Mulder, Catherine Sims, Theresa M. Coles, Robert Overton, Nicoleta Economou-Zavlanos, Rong Zhao, Bhargav Adagarla, Jayanth Doss, Ricardo Henao, Megan E.B. Clowse, Hayden Bosworth, David L. Leverenz The Journal of Rheumatology Aug 2024, 51 (8) 759-764; DOI: 10.3899/jrheum.2024-0014

Jun 26, 2024 | jamanetwork.com | Daniel Edmonston |Elizabeth A. Lydon |Hillary Mulder |Karen Chiswell

Key PointsQuestion  What patient-level risk factors are associated with inadequate screening and treatment for chronic kidney disease (CKD) among people with type 2 diabetes (T2D)? Findings  In this cohort study of 316 234 participants with T2D, fewer than 25% received guideline-recommended CKD screening, and patient-level factors such as Hispanic ethnicity and comorbid cardiovascular disease were associated with concordance with screening recommendations.

Jun 1, 2024 | jacc.org | Daniel Edmonston |Hillary Mulder |Elizabeth A. Lydon |Karen Chiswell

References1. "National Diabetes Statistics Report". 2020. Accessed July 3, 2024. https://doi.org/https://www.cdc.gov/diabetes/php/data-research/data-statistics/index.html. 2. "Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES. 2007-2012". BMJ Open Diabetes Res Care . 2016;4:e000154. 3. "Kidney disease and increased mortality risk in type 2 diabetes". J Am Soc Nephrol . 2013;24:302-308. 4.

May 9, 2024 | jrheum.org | Isaac Smith |Mary Solomon |Hillary Mulder |Catherine Sims

Evaluating factors associated with telehealth appropriateness in outpatient rheumatoid arthritis encounters using the Encounter Appropriateness Score for You (EASY) Isaac D. Smith, Mary J. Solomon, Hillary Mulder, Catherine Sims, Theresa M. Coles, Robert Overton, Nicoleta Economou-Zavlanos, Rong Zhao, Bhargav Adagarla, Jayanth Doss, Ricardo Henao, Megan E. B. Clowse, Hayden Bosworth, David L. Leverenz The Journal of Rheumatology May 2024, jrheum.2024-0014; DOI: 10.3899/jrheum.2024-0014

Mar 9, 2024 | medrxiv.org | Nishant Shah |Hillary Mulder |Betsy Lydon |Karen Chiswell

The authors have declared no competing interest. N/A, this was not a clinical trialNovartis Pharmaceuticals Corporation provided funding with a grant to support this study, including the principle investigators, corresponding author, and statistical support effort. The analytic plan, data analysis, data interpretation, or decision to publish as the study was investigator initiated with collaboration with the sponsor.